Eton Pharmaceutcials
ETON
29 hedge funds and large institutions have $14.6M invested in Eton Pharmaceutcials in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 10 reducing their positions, and 5 closing their positions.
14,017% more call options, than puts
Call options by funds: $847K | Put options by funds: $6K
0.02% less ownership
Funds ownership: 23.48% → 23.46% (-0.02%)
6% less funds holding
Funds holding: 31 → 29 (-2)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
40% less capital invested
Capital invested by funds: $24.2M → $14.6M (-$9.56M)
50% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 10
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WIM
Westside Investment Management
Santa Monica,
California
|
+$347K |
| 2 |
PCMI
Paradigm Capital Management Inc
Albany,
New York
|
+$336K |
| 3 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$279K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$139K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$93.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCBT
First Citizens Bank & Trust
Raleigh,
North Carolina
|
-$436K |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$107K |
| 3 |
Goldman Sachs
New York
|
-$77K |
| 4 |
JP Morgan Chase
New York
|
-$67.6K |
| 5 |
Morgan Stanley
New York
|
-$65.9K |
ETON Hedge Fund Activity: Q2 2022 in Review
29 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Eton Pharmaceutcials (ETON) for Q2 2022, worth a combined $14.6M — down 40% from $24.2M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of ETON and 4 opened new positions — a net loss of 1 holder — while 10 trimmed existing stakes and 5 added.
The largest buyer was Westside Investment Management, adding an estimated $347K. The largest seller was First Citizens Bank & Trust, exiting entirely with an estimated $436K sold.
- 29 institutional investors held Eton Pharmaceutcials (ETON) as of Q2 2022, down from 31 in Q1 2022.
- Funds reported $14.6M of Eton Pharmaceutcials stock for Q2 2022, down 40% quarter-over-quarter.
- 4 funds opened new Eton Pharmaceutcials positions in Q2 2022 and 5 closed out, a net change of -1 holder.
- The largest Eton Pharmaceutcials buyer in Q2 2022 was Westside Investment Management, an estimated $347K added.
- The largest Eton Pharmaceutcials seller in Q2 2022 was First Citizens Bank & Trust, an estimated $436K sold.
Based on aggregated 13F filings for Q2 2022.